{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:57:33Z","timestamp":1778565453524,"version":"3.51.4"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"DOI":"10.1590\/0074-0276130372","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T22:40:19Z","timestamp":1398292819000},"page":"345-351","source":"Crossref","is-referenced-by-count":5,"title":["Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients"],"prefix":"10.1590","volume":"109","author":[{"given":"Tarciana","family":"Grandi","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em Sa\u00fade, Brasil; Universidade Federal do Rio Grande do Sul, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia Maria Dornelles da","family":"Silva","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em Sa\u00fade, Brasil; Universidade Luterana do Brasil, Brasil; Universidade Luterana do Brasil, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine Medeiros","family":"Amaral","sequence":"additional","affiliation":[{"name":"Centro de Aplica\u00e7\u00e3o e Monitoriza\u00e7\u00e3o de Medicamentos Injet\u00e1veis, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Dornelles","family":"Picon","sequence":"additional","affiliation":[{"name":"Centro de Aplica\u00e7\u00e3o e Monitoriza\u00e7\u00e3o de Medicamentos Injet\u00e1veis, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cintia","family":"Costi","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em Sa\u00fade, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole Nascimento da","family":"Fr\u00e9","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em Sa\u00fade, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilu","family":"Fiegenbaum","sequence":"additional","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade, Brasil; Universidade Federal de Ci\u00eancias da Sa\u00fade, Brasil; Centro Universit\u00e1rio Metodista, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Sch\u00e4ffer","family":"Gregianini","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em Sa\u00fade, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Niel","sequence":"additional","affiliation":[{"name":"Instituto Oswaldo Cruz-Fiocruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lucia Rosa","family":"Rossetti","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Estadual de Produ\u00e7\u00e3o e Pesquisa em Sa\u00fade, Brasil; Universidade Federal do Rio Grande do Sul, Brasil; Universidade Luterana do Brasil, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2014,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/303004","article-title":"The ancestry of Brazilian mtDNA lineages","volume":"67","author":"Alves-Silva J","year":"2000","journal-title":"Am J Hum Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/vim.2011.0052","article-title":"Hepatitis C virus spontaneous clearance: immunology and genetic variance","volume":"25","author":"Amini M","year":"2012","journal-title":"Viral Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jmv.10472","article-title":"Polymorphisms in tumour necrosis factor-alpha, transforming growth factor beta, interleukin-10, interleukin-6, interferon-gamma and outcome of hepatitis C virus infection","volume":"71","author":"Barrett S","year":"2003","journal-title":"J Med Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1440-1746.2006.04304.x","article-title":"Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms","volume":"21","author":"Cheong JY","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.dld.2008.09.017","article-title":"IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients","volume":"41","author":"Chuang JY","year":"2009","journal-title":"Dig Liver Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2006.06.008","article-title":"Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1","volume":"131","author":"Conjeevaram HS","year":"2006","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/498244","article-title":"Tumor necrosis factor-alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection","volume":"193","author":"Dai CY","year":"2006","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.humimm.2011.06.008","article-title":"Polymorphism of tumor necrosis factor-? and interleukin-10 gene promoter region in chronic hepatitis C virus patients and their effect on pegylated interferon-? therapy response","volume":"72","author":"Dogra G","year":"2011","journal-title":"Hum Immunol"},{"key":"ref9","first-page":"47","article-title":"Arlequin (version 3.0): an integrated software package for population genetics data analysis","volume":"1","author":"Excoffier L","year":"2007","journal-title":"Evol Bioinform Online"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried MW","year":"2002","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL-28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge D","year":"2009","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/S0074-02762013000100008","article-title":"Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene","volume":"108","author":"Grandi T","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis SJ","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000025035","article-title":"Identification of a single nucleotide polymorphism in the MxA gene promoter (G\/T at nt -88) correlated with response of hepatitis C patients interferon","volume":"43","author":"Hijikata M","year":"2000","journal-title":"Intervirology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000050075","article-title":"Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro","volume":"44","author":"Hijikata M","year":"2001","journal-title":"Intervirology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2","article-title":"Tumor necrosis factor alpha promoter polymorphism at position-238 is associated with chronic active hepatitis C","volume":"54","author":"Hohler T","year":"1998","journal-title":"J Med Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00251-003-0594-5","article-title":"Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection","volume":"55","author":"Knapp S","year":"2003","journal-title":"Immunogenetics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.gene.6363984","article-title":"Polymorphisms in interferon induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR","volume":"4","author":"Knapp S","year":"2003","journal-title":"Genes Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2006.03.011","article-title":"Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan","volume":"34","author":"Kusumoto K","year":"2006","journal-title":"Cytokine"},{"key":"ref20","first-page":"210","article-title":"Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C","volume":"23","author":"Larrea E","year":"1996","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1053\/jhep.2003.50217","article-title":"Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin","volume":"37","author":"Layden-Almer JE","year":"2003","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/genetics\/120.3.849","article-title":"On measures of gametic disequilibrium","volume":"120","author":"Lewontin RC","year":"1998","journal-title":"Genetics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cyto.2003.10.005","article-title":"IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection","volume":"25","author":"Mangia A","year":"2004","journal-title":"Cytokine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.510240402","article-title":"Progressive liver injury in chronic hepatitis C infection correlates with increased intra-hepatic expression of Th1 associated cytokines","volume":"24","author":"Napoli J","year":"1996","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cyto.2004.07.014","article-title":"Cytokine genes and disease susceptibility","volume":"28","author":"Ollier WE","year":"2004","journal-title":"Cytokine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cyto.2012.11.003","article-title":"Cytokines genes polymorphisms in chronic hepatitis C: impact on susceptibility to infection and response to therapy","volume":"61","author":"Pasha HF","year":"2013","journal-title":"Cytokine"},{"key":"ref27","article-title":"The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected.","volume":"6","author":"Pena SD","year":"2011","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jhep.2006.07.026","article-title":"Interleukin-10 -1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection","volume":"45","author":"Persico M","year":"2006","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1478-3231.2011.02449.x","article-title":"Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment","volume":"31","author":"Romero-Gomez M","year":"2011","journal-title":"Liver Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1572-0241.2002.05552.x","article-title":"Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C","volume":"97","author":"Rosen HR","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/ard.2004.025809","article-title":"Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10 and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener?s granulomatosis.","volume":"64","author":"Spriewald BM","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management and treatment of hepatitis C","volume":"39","author":"Strader DB","year":"2004","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL-28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah V","year":"2009","journal-title":"Nat Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2893.2004.00509.x","article-title":"Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection","volume":"11","author":"Suzuki F","year":"2004","journal-title":"J Viral Hepat"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL-28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka Y","year":"2009","journal-title":"Nat Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cld.2008.03.002","article-title":"Host genetic factors and antiviral immune responses to hepatitis C virus","volume":"12","author":"Thio CL","year":"2008","journal-title":"Clin Liver Dis"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047725","article-title":"Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL-28B and SOCS3 gene variants","volume":"7","author":"Vidal F","year":"2012","journal-title":"PLoS ONE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-8278(01)00243-4","article-title":"Polymorphisms in the interleukin-10, tumor necrosis factor-alpha and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin","volume":"36","author":"Vidigal PG","year":"2002","journal-title":"J Hepatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/324771","article-title":"Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma","volume":"185","author":"Wu MS","year":"2002","journal-title":"J Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/jhep.2001.22347","article-title":"Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection","volume":"33","author":"Yee LJ","year":"2001","journal-title":"Hepatology"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/mioc\/v109n3\/0074-0276-mioc-109-3-0345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:25:28Z","timestamp":1648877128000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762014000300345&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,6]]}},"alternative-id":["S0074-02762014000300345"],"URL":"https:\/\/doi.org\/10.1590\/0074-0276130372","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"value":"1678-8060","type":"electronic"},{"value":"0074-0276","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}